NCT06960148

Brief Summary

Assess the clinical efficacy of CSPR Toothpaste containing 8% arginine to provide dentinal hypersensitivity relief

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Mar 2025

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 4, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 22, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 7, 2025

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 13, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 13, 2025

Completed
Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

2 months

First QC Date

April 22, 2025

Last Update Submit

March 17, 2026

Conditions

Keywords

hypersensitivitydentin

Outcome Measures

Primary Outcomes (2)

  • Tactile Sensitivity using the Yeaple Electronic Force Sensing Probe

    Tactile sensitivity will be assessed by use of Sensing Probe Yeaple Electronic Force Sensing Probe, Model 200A. Sensitivity will be defined by a score in the range of 10-50 gms. of force.

    baseline, 3 day, 4 weeks, 8 weeks

  • Air Sensitivity using the Schiff Cold Air Sensitivity Scale

    The air will be directed at the exposed buccal surface of the sensitive tooth air delivered by a standard dental unit syringe at a measured temperature of 19-21°C (70°F\[± 3°F\].

    baseline, 3 day, 4 weeks, 8 weeks

Study Arms (2)

Test Toothpaste

EXPERIMENTAL

Subjects will be instructed to brush their teeth with their assigned teeth dentifrice and toothbrush twice daily

Drug: CSPR Toothpaste

Control toothpaste

ACTIVE COMPARATOR

Subjects will be instructed to brush their teeth with their assigned teeth dentifrice and toothbrush twice daily

Drug: Colgate Dental Cream Toothpaste

Interventions

a commercially available 8% arginine toothpaste

Test Toothpaste

a commercially available fluoride toothpaste

Control toothpaste

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female subjects, ages 18-70, inclusive.
  • Availability for the eight-week duration of the study.
  • Two sensitive teeth, which must be anterior to the molars, and demonstrate cervical erosion/abrasion or gingival recession.
  • Qualifying response to tactile stimuli (Yeaple probe) as defined by a score between 10-50 gms. of force.
  • Qualifying response to the air blast stimuli as defined by a score of 2 or 3 on the Schiff Cold Air Sensitivity Scale.
  • Subjects need to satisfy the qualifying response to stimuli for both the parameters assessed (tactile or air) on two teeth to be entered into the study.
  • Good general health with no known allergies to products being tested.
  • Use of a non-desensitizing dentifrice for three months prior to entry into the study.
  • Signed Informed Consent Form.

You may not qualify if:

  • Gross oral pathology, chronic disease, or history of allergy to test products. 2. Advanced periodontal disease or treatment for periodontal disease (including surgery) within the past twelve months.
  • Sensitive teeth with a mobility greater than one.
  • Teeth with extensive/defective restorations (including prosthetic crowns), suspected pulpitis, caries, cracked enamel, or used as abutments for removable partial dentures.
  • Current use of anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory drugs, or daily use of analgesics.
  • Participation in a desensitizing dentifrice study or regular use of a desensitizing dentifrice within the past three months.
  • Current participation in any other clinical study.
  • Pregnant or lactating subjects.
  • Allergies to oral care products, personal care consumer products, or their ingredients.
  • Medical condition which prohibits not eating/drinking for 4 hours.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West China Dental Institute of Chengdu

Chengdu, Sichuan, 610041, China

Location

MeSH Terms

Conditions

Dentin SensitivityHypersensitivity

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic DiseasesImmune System Diseases

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The tubes of test dentifrices will present the same shape/color to avoid that both investigators and subjects can identify the dentifrices.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study will be monocentric, randomized, double-blind, two-treatment, parallel clinical study
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 22, 2025

First Posted

May 7, 2025

Study Start

March 4, 2025

Primary Completion

May 13, 2025

Study Completion

May 13, 2025

Last Updated

March 19, 2026

Record last verified: 2026-03

Locations